# Pilot Study to Evaluate the Efficacy and Safety of Quetiapine Fumarate Instant-Release (Seroquel IR) in Controlling Agitation and Aggressive Symptoms in the Acute Treatment of Patients With Schizophrenia

> **NCT00838032** · PHASE4 · UNKNOWN · sponsor: **Sichuan University** · enrollment: 70 (estimated)

## Conditions studied

- Acute Schizophrenia

## Interventions

- **DRUG:** Quetiapine fumarate
- **DRUG:** Haloperidol

## Key facts

- **NCT ID:** NCT00838032
- **Lead sponsor:** Sichuan University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-08
- **Primary completion:** 2010-05
- **Final completion:** 2010-05
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2009-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00838032

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00838032, "Pilot Study to Evaluate the Efficacy and Safety of Quetiapine Fumarate Instant-Release (Seroquel IR) in Controlling Agitation and Aggressive Symptoms in the Acute Treatment of Patients With Schizophrenia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00838032. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*